Mealey's (May 18, 2020, 2:05 PM EDT) -- CHICAGO — In a May 13 opinion, a federal judge in Illinois ruled that a drug development company pleaded with sufficient particularity that it took reasonable efforts to maintain the secrecy of its trade secret information pertaining to the production of its cancer treatment drug, rejecting an argument by a former business partner that the company failed to do so as required under Illinois trade secret law (Meridian Laboratories Inc. v. OncoGenerix USA Inc., No. 18-6007, N.D. Ill., 2020 U.S. Dist. LEXIS 84352)....